Skip to content

Role of low level laser therapy on pain intensity and quality of life in patients with diabetic neuropathy

Role of low level laser therapy on pain intensity and quality of life in patients with diabetic neuropathy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190618043931N1
Enrollment
40
Registered
2020-01-20
Start date
2016-03-20
Completion date
Unknown
Last updated
2020-02-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painful diabetic neuropathy: Painful diabetic neuropathy (PDN) is a common and debilitating complication of both types of diabetes mellitus. With this disorder the patients’ sleep, mood, function and mainly quality of life (QOL) will be disturbed.. Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified

Interventions

Intervention 1: Intervention group: These patients will receive 8 sessions of low power laser. Treatments were administered twice weekly for 4 weeks. Intervention 2: Control group: These patients will

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients with painful peripheral neuropathy older than 18 years of age Willingness to participate in the research project (filling the consent letter)

Exclusion criteria

Exclusion criteria: malignancy Active or untreated thyroid disease Infection with other known neurological and masculo-skeletal disorders simultaneously in the lower extremity

Design outcomes

Primary

MeasureTime frame
Pain and quality of life in patients with diabetic neuropathy. Timepoint: Before the intervention, immediately, 1 week and 1 week after the end of treatment in each group. Method of measurement: Pain intensity using VAS criteria and quality of life using SF36 questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNajmeh Zare Zardini

Esfahan University of Medical Sciences

zarenajme920@gmaail.com+98 31 3668 0048

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026